Association of Vascular Risk With Severe vs Non-Severe Stroke An Analysis of the INTERSTROKE Study

dc.authorid0000-0002-6396-5913
dc.authorid0000-0002-6044-7328
dc.authorid0000-0001-6841-4830
dc.contributor.authorReddin, Catriona
dc.contributor.authorCanavan, Michelle
dc.contributor.authorHankey, Graeme J.
dc.contributor.authorOveisgharan, Shahram
dc.contributor.authorLanghorne, Peter
dc.contributor.authorWang, Xingyu
dc.contributor.authorIversen, Helle Klingenberg
dc.date.accessioned2025-05-10T19:34:32Z
dc.date.issued2024
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractBackground and objectives Acute stroke is associated with a spectrum of functional deficits. The objective of this analysis was to explore whether the importance of individual risk factors differ by stroke severity, which may be of relevance to public health strategies to reduce disability. Methods INTERSTROKE is an international case-control study of risk factors of first acute stroke (recruitment 2007-August 2015) in 32 countries. Stroke severity was measured using the modified Rankin Scale (mRS) score within 72 hours of admission to hospital. Severe stroke is defined as mRS scores of 4-6 (and non-severe stroke, score of 0-3). We used multinomial logistic regression to estimate comparative odds ratios (ORs; 95% CIs) for severe and non-severe stroke and tested for heterogeneity (p(heterogeneity)). We also conducted a matched case-case analysis (matched for age, sex, country, and primary stroke subtype) to determine whether the prevalence of risk factors differed significantly between severe and non-severe stroke. A significant difference in the association of a risk factor of severe stroke compared with non-severe stroke was defined as p < 0.05 for both p(heterogeneity) and p(case-case). Results Of patients with acute stroke (n = 13,460), 64.0% (n = 8,612) were reported to have mRS scores of 0-3 and 36.0% (n = 4,848) scores of 4-6. The mean age was 61.7 years for patients with non-severe stroke and 62.9 years for patients with severe stroke (p = 0.72). 38.1% (n = 3,278) of patients with non-severe stroke and 44.6% (n = 2,162) of patients with severe stroke were female. Hypertension (OR 3.21; 95% CI 2.97-3.47 for severe stroke, OR 2.87; 95% CI 2.69-3.05 for non-severe stroke; p(heterogeneity) = 0.03; p(case-case) < 0.001), atrial fibrillation (OR 4.70; 95% CI 4.05-5.45 for severe stroke, OR 3.61; 95% CI 3.16-4.13 for non-severe stroke; p(heterogeneity) = 0.009; p(case-case) < 0.001), and smoking (OR 1.87; 95% CI 1.72-2.03 for severe stroke, OR 1.65; 95% CI 1.54-1.77 for non-severe stroke; p(heterogeneity) = 0.02; p(case-case) < 0.001) had a stronger association with severe stroke, compared with non-severe stroke. The waist-to-hip ratio had a stronger association with non-severe stroke compared with severe stroke (p(heterogeneity) < 0.001; p(case-case) < 0.001). Discussion Hypertension, atrial fibrillation, and smoking had a stronger magnitude of association with severe stroke (compared with non-severe stroke) while the increased waist-to-hip ratio had a stronger magnitude of association with non-severe stroke.
dc.description.sponsorshipCanadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Canadian Stroke Network; Swedish Research Council; Swedish Heart and Lung Foundation; Health & Medical Care Committee of the Regional Executive Board, Regiona Vastra Gotaland (Sweden); AstraZeneca; Boehringer Ingelheim (Canada); Pfizer (Canada); MSD; Chest, Heart and Stroke Scotland; Stroke Association; UK Stroke Research Network; German Research Council (DFG); German Ministry of Education and Research (BMBF); European Union; NIH; Bertelsmann Foundation; Heinz-Nixdorf Foundation; Irish Clinical Academic Training (ICAT) Programme; Wellcome Trust; Health Research Board [203930/B/16/Z]; Health Service Executive, National Doctors Training and Planning; Health and Social Care, Research and Development Division, Northern Ireland
dc.description.sponsorshipThe INTERSTROKE study was funded by the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, Canadian Stroke Network, Swedish Research Council, Swedish Heart and Lung Foundation, The Health & Medical Care Committee of the Regional Executive Board, Regiona Vastra Gotaland (Sweden), and through unrestricted grants from several pharmaceutical companies with major contributions from AstraZeneca, Boehringer Ingelheim (Canada), Pfizer (Canada), MSD, Chest, Heart and Stroke Scotland, and the Stroke Association, with support from The UK Stroke Research Network. The Department of Neurology at the University Duisburg-Essen received research grants from the German Research Council (DFG), German Ministry of Education and Research (BMBF), European Union, NIH, Bertelsmann Foundation, and Heinz-Nixdorf Foundation.CR was supported by the Irish Clinical Academic Training (ICAT) Programme, the Wellcome Trust and the Health Research Board (grant number 203930/B/16/Z), the Health Service Executive, National Doctors Training and Planning, and the Health and Social Care, Research and Development Division, Northern Ireland.
dc.identifier.doi10.1212/WNL.0000000000210087
dc.identifier.issn0028-3878
dc.identifier.issn1526-632X
dc.identifier.issue11
dc.identifier.pmid39536279
dc.identifier.scopus2-s2.0-85209393401
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1212/WNL.0000000000210087
dc.identifier.urihttps://hdl.handle.net/20.500.14730/8557
dc.identifier.volume103
dc.identifier.wosWOS:001397596800001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofNeurology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectAtrial-Fibrillation
dc.subjectCountries
dc.subjectMortality
dc.titleAssociation of Vascular Risk With Severe vs Non-Severe Stroke An Analysis of the INTERSTROKE Study
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
8557.pdf
Boyut:
251.79 KB
Biçim:
Adobe Portable Document Format